• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[凝血致活酶(因子III)蛋白质部分的修饰对其活性的影响]

[Effect of modifications of the protein moiety of thromboplastin (factor III) on its activity].

作者信息

Zubairov D M, Soboleva I V, Vazhinskaia Z V, Chenborisova G Sh, Timerbaev V N

出版信息

Biokhimiia. 1981 Jul;46(7):1210-4.

PMID:6791705
Abstract

The role of protein moiety of tissue thromboplastin under its specific enzymatic modification and the effects of some protease inhibitors were studied. Treatment with HCl, pepsin and papain was followed by a decrease in the biological activity of thromboplastin, which was unaffected by the inhibitors of some proteolytic enzymes (DFP, monoiodoacetate and o-phenanthroline). It was assumed that the protein component of thromboplastin fulfils a structural function in the assembly of the lipoprotein matrix, on which surface the enzymatic reactions of blood coagulation are known to occur.

摘要

研究了组织凝血活酶蛋白质部分在其特定酶修饰下的作用以及一些蛋白酶抑制剂的影响。用盐酸、胃蛋白酶和木瓜蛋白酶处理后,凝血活酶的生物活性降低,而一些蛋白水解酶抑制剂(二异丙基氟磷酸、一碘乙酸和邻菲罗啉)对此无影响。据推测,凝血活酶的蛋白质成分在脂蛋白基质组装中起结构作用,已知血液凝固的酶促反应发生在该基质表面。

相似文献

1
[Effect of modifications of the protein moiety of thromboplastin (factor III) on its activity].[凝血致活酶(因子III)蛋白质部分的修饰对其活性的影响]
Biokhimiia. 1981 Jul;46(7):1210-4.
2
[Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X].
Biokhimiia. 1984 Jun;49(6):971-5.
3
Modulatory impact of acid and pepsin on esophageal hydrophobicity in humans.酸和胃蛋白酶对人体食管疏水性的调节作用。
Am J Gastroenterol. 1995 Nov;90(11):2020-4.
4
Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.一种与组织因子途径抑制剂同源的新型人Kunitz型蛋白酶抑制剂的抑制特性
Biochemistry. 1996 Jan 9;35(1):266-72. doi: 10.1021/bi951501d.
5
Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal kinase and p38.蛋白酶抑制剂通过使Jun-N端激酶和p38磷酸化激活激活蛋白-1(AP-1),从而诱导人单核细胞中组织因子的表达。
Thromb Res. 2003;112(5-6):313-20. doi: 10.1016/j.thromres.2003.12.018.
6
Tissue factor activity and function in blood coagulation.组织因子在血液凝固中的活性与功能。
Thromb Res. 2008;122 Suppl 1:S42-6. doi: 10.1016/S0049-3848(08)70018-5.
7
Regulation of tissue factor procoagulant activity by post-translational modifications.通过翻译后修饰对组织因子促凝活性的调控。
Thromb Res. 2008;122(6):831-7. doi: 10.1016/j.thromres.2007.11.004. Epub 2008 Jan 8.
8
Lipid activation of coagulation factor III apoprotein (tissue factor)--reconstitution of the protein-membrane complex.凝血因子III载脂蛋白(组织因子)的脂质激活——蛋白质-膜复合物的重构
Thromb Haemost. 1980 Aug 29;44(1):12-5.
9
Papain inhibitions by optically active E-64 analogs.光学活性E-64类似物对木瓜蛋白酶的抑制作用。
J Biochem. 1981 Jul;90(1):255-7. doi: 10.1093/oxfordjournals.jbchem.a133458.
10
Miraziridine A: natures blueprint towards protease class-spanning inhibitors.米拉萨立啶A:迈向跨蛋白酶类抑制剂的自然蓝图。
Bioorg Med Chem Lett. 2004 Feb 23;14(4):855-7. doi: 10.1016/j.bmcl.2003.12.030.